Meyer B - Search Results

1

How to calculate clearance of highly protein-bound drugs during continuous venovenous hemofiltration demonstrated with flucloxacillin.

Meyer B, Ahmed el Gendy S, Delle Karth G, Locker GJ, Heinz G, Jaeger W, Thalhammer F. Meyer B, et al. Kidney Blood Press Res. 2003;26(2):135-40. doi: 10.1159/000070997. Kidney Blood Press Res. 2003. PMID: 12771540 Clinical Trial.

2

Multiple-dose pharmacokinetics of linezolid during continuous venovenous haemofiltration.

Meyer B, Kornek GV, Nikfardjam M, Karth GD, Heinz G, Locker GJ, Jaeger W, Thalhammer F. Meyer B, et al. J Antimicrob Chemother. 2005 Jul;56(1):172-9. doi: 10.1093/jac/dki133. Epub 2005 May 19. J Antimicrob Chemother. 2005. PMID: 15905303

3

Single-dose pharmacokinetics of fosfomycin during continuous venovenous haemofiltration.

Gattringer R, Meyer B, Heinz G, Guttmann C, Zeitlinger M, Joukhadar C, Dittrich P, Thalhammer F. Gattringer R, et al. Among authors: meyer b. J Antimicrob Chemother. 2006 Aug;58(2):367-71. doi: 10.1093/jac/dkl251. Epub 2006 Jun 16. J Antimicrob Chemother. 2006. PMID: 16782745

4

Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage.

Meyer B, Traunmüller F, Hamwi A, Hollenstein UM, Locker GJ, Sperr WR, Staudinger T, Thalhammer-Scherrer R, Burgmann H, Thalhammer F. Meyer B, et al. Int J Clin Pharmacol Ther. 2004 Oct;42(10):556-60. doi: 10.5414/cpp42556. Int J Clin Pharmacol Ther. 2004. PMID: 15516025 Clinical Trial.

5

Single-dose pharmacokinetics of cefodizime in critically ill elderly patients.

Meyer B, Traunmueller F, Bojic A, Locker G, Schmid R, Winkler S, Thalhammer F. Meyer B, et al. Int J Antimicrob Agents. 2006 Apr;27(4):335-8. doi: 10.1016/j.ijantimicag.2005.11.018. Epub 2006 Mar 24. Int J Antimicrob Agents. 2006. PMID: 16563704

6

Multiple-dose pharmacokinetics of anidulafungin during continuous venovenous haemofiltration.

Leitner JM, Meyer B, Fuhrmann V, Saria K, Zuba C, Jäger W, Böhmdorfer M, Thalhammer F. Leitner JM, et al. Among authors: meyer b. J Antimicrob Chemother. 2011 Apr;66(4):880-4. doi: 10.1093/jac/dkq545. Epub 2011 Jan 22. J Antimicrob Chemother. 2011. PMID: 21393208

7

Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.

Wenisch JM, Meyer B, Fuhrmann V, Saria K, Zuba C, Dittrich P, Thalhammer F. Wenisch JM, et al. Among authors: meyer b. J Antimicrob Chemother. 2012 Apr;67(4):977-83. doi: 10.1093/jac/dkr551. Epub 2011 Dec 29. J Antimicrob Chemother. 2012. PMID: 22210754

8

Dynamics of inflammation parameters prior to tachyarrhythmias in critically ill patients.

Koreny M, Reinelt P, Meyer B, Delle Karth G, Geppert A, Hülsmann M, Priglinger U, Berger R, Heinz G. Koreny M, et al. Among authors: meyer b. Wien Klin Wochenschr. 2005 May;117(9-10):342-7. doi: 10.1007/s00508-005-0356-5. Wien Klin Wochenschr. 2005. PMID: 15989113 Clinical Trial.

9

Linezolid and continuous venovenous hemofiltration.

Meyer B, Thalhammer F. Meyer B, et al. Clin Infect Dis. 2006 Feb 1;42(3):435-6; author reply 437-8. doi: 10.1086/499536. Clin Infect Dis. 2006. PMID: 16392097 No abstract available.

10

Outcome and functional capacity after prolonged intensive care unit stay.

Delle Karth G, Meyer B, Bauer S, Nikfardjam M, Heinz G. Delle Karth G, et al. Among authors: meyer b. Wien Klin Wochenschr. 2006 Jul;118(13-14):390-6. doi: 10.1007/s00508-006-0616-z. Wien Klin Wochenschr. 2006. PMID: 16865643

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,335 results

Search Page